Literature DB >> 28497525

Risk of End-Stage Renal Disease in HIV-Positive Potential Live Kidney Donors.

A D Muzaale1, K N Althoff2, C J Sperati3, A G Abraham2, L M Kucirka1,2, A B Massie1,2, M M Kitahata4, M A Horberg5, A C Justice6, M J Fischer7, M J Silverberg8, A A Butt9,10,11, S L Boswell12, A R Rachlis13, A M Mayor14, M J Gill15, J J Eron16, S Napravnik16, D R Drozd17, J N Martin18, R J Bosch19, C M Durand3, J E Locke20, R D Moore3, G M Lucas3, D L Segev1,2.   

Abstract

New federal regulations allow HIV-positive individuals to be live kidney donors; however, potential candidacy for donation is poorly understood given the increased risk of end-stage renal disease (ESRD) associated with HIV infection. To better understand this risk, we compared the incidence of ESRD among 41 968 HIV-positive participants of North America AIDS Cohort Collaboration on Research and Design followed for a median of 5 years with the incidence of ESRD among comparable HIV-negative participants of National Health and Nutrition Examination III followed for a median of 14 years. We used risk associations from multivariable Cox proportional hazards regression to derive cumulative incidence estimates for selected HIV-positive scenarios (no history of diabetes, hypertension, AIDS, or hepatitis C virus coinfection) and compared these estimates with those from similarly selected HIV-negative scenarios. For 40-year-old HIV-positive individuals with health characteristics that were similar to those of age-matched kidney donors, viral load <400 copies/mL, and CD4+ count ≥500 cells/μL, the 9-year cumulative incidence of ESRD was higher than that of their HIV-negative peers, yet still low: 2.5 versus 1.1 per 10 000 among white women, 3.0 versus 1.3 per 10 000 among white men, 13.2 versus 3.6 per 10 000 among black women, and 15.8 versus 4.4 per 10 000 among black men. HIV-positive individuals with no comorbidities and well-controlled disease may be considered low-risk kidney donor candidates.
© 2017 The American Society of Transplantation and the American Society of Transplant Surgeons.

Entities:  

Keywords:  clinical research/practice; donors and donation: living; infection and infectious agents; infectious disease; kidney transplantation/nephrology; viral: human immunodeficiency virus (HIV)/acquired immunodeficiency syndrome (AIDS)

Mesh:

Year:  2017        PMID: 28497525      PMCID: PMC5489376          DOI: 10.1111/ajt.14235

Source DB:  PubMed          Journal:  Am J Transplant        ISSN: 1600-6135            Impact factor:   8.086


  40 in total

1.  The Risks of Living Kidney Donation.

Authors:  Robert W Steiner
Journal:  N Engl J Med       Date:  2015-11-06       Impact factor: 91.245

2.  Evaluation of living renal donors. The current practice of US transplant centers.

Authors:  M J Bia; E L Ramos; G M Danovitch; R S Gaston; W E Harmon; A B Leichtman; P A Lundin; J Neylan; B L Kasiske
Journal:  Transplantation       Date:  1995-08-27       Impact factor: 4.939

Review 3.  Systemic and glomerular hypertension and progression of chronic renal disease: the dilemma of nephrosclerosis.

Authors:  Rafael Marín; Manuel Gorostidi; Francisco Fernández-Vega; Rafael Alvarez-Navascués
Journal:  Kidney Int Suppl       Date:  2005-12       Impact factor: 10.545

4.  Renal transplantation between HIV-positive donors and recipients.

Authors:  Elmi Muller; Delawir Kahn; Marc Mendelson
Journal:  N Engl J Med       Date:  2010-06-17       Impact factor: 91.245

5.  APOL1 genetic variants in focal segmental glomerulosclerosis and HIV-associated nephropathy.

Authors:  Jeffrey B Kopp; George W Nelson; Karmini Sampath; Randall C Johnson; Giulio Genovese; Ping An; David Friedman; William Briggs; Richard Dart; Stephen Korbet; Michele H Mokrzycki; Paul L Kimmel; Sophie Limou; Tejinder S Ahuja; Jeffrey S Berns; Justyna Fryc; Eric E Simon; Michael C Smith; Howard Trachtman; Donna M Michel; Jeffrey R Schelling; David Vlahov; Martin Pollak; Cheryl A Winkler
Journal:  J Am Soc Nephrol       Date:  2011-10-13       Impact factor: 10.121

6.  Body mass index and the risk of development of end-stage renal disease in a screened cohort.

Authors:  Kunitoshi Iseki; Yoshiharu Ikemiya; Kozen Kinjo; Taku Inoue; Chiho Iseki; Shuichi Takishita
Journal:  Kidney Int       Date:  2004-05       Impact factor: 10.612

7.  Advanced chronic kidney disease, end-stage renal disease and renal death among HIV-positive individuals in Europe.

Authors:  L Ryom; O Kirk; J D Lundgren; P Reiss; C Pedersen; S De Wit; S Buzunova; J Gasiorowski; J M Gatell; A Mocroft
Journal:  HIV Med       Date:  2013-04-16       Impact factor: 3.180

8.  Racial differences in end-stage renal disease rates in HIV infection versus diabetes.

Authors:  Andy I Choi; Rudolph A Rodriguez; Peter Bacchetti; Daniel Bertenthal; Paul A Volberding; Ann M O'Hare
Journal:  J Am Soc Nephrol       Date:  2007-10-17       Impact factor: 10.121

9.  NHANES III: influence of race on GFR thresholds and detection of metabolic abnormalities.

Authors:  Robert N Foley; Changchun Wang; Areef Ishani; Allan J Collins
Journal:  J Am Soc Nephrol       Date:  2007-07-26       Impact factor: 10.121

10.  U.S. trends in antiretroviral therapy use, HIV RNA plasma viral loads, and CD4 T-lymphocyte cell counts among HIV-infected persons, 2000 to 2008.

Authors:  Keri N Althoff; Kate Buchacz; H Irene Hall; Jinbing Zhang; David B Hanna; Peter Rebeiro; Stephen J Gange; Richard D Moore; Mari M Kitahata; Kelly A Gebo; Jeffrey Martin; Amy C Justice; Michael A Horberg; Robert S Hogg; Timothy R Sterling; Angela Cescon; Marina B Klein; Jennifer E Thorne; Heidi M Crane; Michael J Mugavero; Sonia Napravnik; Gregory D Kirk; Lisa P Jacobson; John T Brooks
Journal:  Ann Intern Med       Date:  2012-09-04       Impact factor: 25.391

View more
  6 in total

1.  Living kidney donation in individuals with hepatitis C and HIV infection: rationale and emerging evidence.

Authors:  Luckmini Liyanage; Abimereki D Muzaale; Macey L Henderson; Christine M Durand
Journal:  Curr Transplant Rep       Date:  2019-04-30

Review 2.  Kidney Transplantation in Patients with HIV.

Authors:  Deirdre Sawinski
Journal:  Kidney360       Date:  2020-05-06

3.  Perceptions, motivations, and concerns about living organ donation among people living with HIV.

Authors:  Sarah E Van Pilsum Rasmussen; Macey L Henderson; Juli Bollinger; Shanti Seaman; Diane Brown; Christine M Durand; Dorry L Segev; Jeremy Sugarman
Journal:  AIDS Care       Date:  2018-05-03

4.  Knowledge, attitudes, and planned practice of HIV-positive to HIV-positive transplantation in US transplant centers.

Authors:  Sarah E Van Pilsum Rasmussen; Mary Grace Bowring; Ashton A Shaffer; Macey L Henderson; Allan Massie; Aaron A R Tobian; Dorry L Segev; Christine M Durand
Journal:  Clin Transplant       Date:  2018-08-31       Impact factor: 2.863

Review 5.  The future of HIV Organ Policy Equity Act is now: the state of HIV+ to HIV+ kidney transplantation in the United States.

Authors:  Brian J Boyarsky; Mary Grace Bowring; Ashton A Shaffer; Dorry L Segev; Christine M Durand
Journal:  Curr Opin Organ Transplant       Date:  2019-08       Impact factor: 2.640

6.  Canadian Society of Transplantation and Canadian Society of Nephrology Commentary on the 2017 KDIGO Clinical Practice Guideline on the Evaluation and Care of Living Kidney Donors.

Authors:  Ngan N Lam; Christine Dipchand; Marie-Chantal Fortin; Bethany J Foster; Anand Ghanekar; Isabelle Houde; Bryce Kiberd; Scott Klarenbach; Greg A Knoll; David Landsberg; Patrick P Luke; Rahul Mainra; Sunita K Singh; Leroy Storsley; Jagbir Gill
Journal:  Can J Kidney Health Dis       Date:  2020-06-09
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.